Ultomiris 1,100 mg/11 mL concentrate for solution for infusion, Anti C5 Complement mAb Placebo
ALXN1210-DGF-321
Phase 3 small_molecule active
Quick answer
Ultomiris 1,100 mg/11 mL concentrate for solution for infusion, Anti C5 Complement mAb Placebo for Delayed Graft Function after Kidney Transplantation is a Phase 3 program (small_molecule) at Alexion Europe SAS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alexion Europe SAS
- Indication
- Delayed Graft Function after Kidney Transplantation
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active